Dynamic gene expression during the onset of myoblast differentiation in vitro

Genomics

Volumn 82, Issue 2, 2003, Pages 109-121

  Delgado, Ivan ^a   Huang, Xingxu ^a   Jones, Sara ^a   Zhang, Lingna ^a   Hatcher, Rashieda ^a   Gao, Bifeng ^b   Zhang, Pumin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Univ of CO Compreh Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DYNAMICS; GENE EXPRESSION; GENE NUMBER; GENETIC TRANSCRIPTION; IN VITRO STUDY; INTERCELLULAR SPACE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETON;

EID: 0038386711     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-7543(03)00104-6     Document Type: Article

References (59)

1. Olson E.N., Klein W.H. bHLH factors in muscle development dead lines and commitments, what to leave in and what to leave out . Genes Dev. 8:1994;1-8.
2. Molkentin J.D., Black B.L., Martin J.F., Olson E.N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1995;1125-1136.
3. Bischoff R., Holtzer H. Mitosis and the processes of differentiation of myogenic cells in vitro. J. Cell Biol. 41:1969;188-200.
4. Nadal-Ginard B. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell. 15:1978;855-864.
5. Zhang P., Wong C., Liu D., Finegold M., Harper J.W., Elledge S.J. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev. 13:1999;213-224.
6. Nead M.A., Baglia L.A., Antinore M.J., Ludlow J.W., McCance D.J. Rb binds c-Jun and activates transcription. EMBO J. 17:1998;2342-2352.
7. Chen P.L., Riley D.J., Chen Y., Lee W.H. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:1996;2794-2804.
8. Zacksenhaus E., Jiang Z., Chung D., Marth J.D., Phillips R.A., Gallie B.L. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:1996;3051-3064.
9. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 270:1977;725-727.
10. Blau H.M., Pavlath G.K., Hardeman E.C., Chiu C.P., Silberstein L., Webster S.G., Miller S.C., Webster C. Plasticity of the differentiated state. Science. 230:1985;758-766.
11. Li L., Zhou J., James G., Heller-Harrison R., Czech M.P., Olson E.N. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell. 71:1992;1181-1194.
12. Kelkar N., Gupta S., Dickens M., Davis R.J. Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol. Cell. Biol. 20:2000;1030-1043.
13. Bergstrom D.A., Penn B.H., Strand A., Perry R.L., Rudnicki M.A., Tapscott S.J. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell. 9:2002;587-600.
14. Parker S.B., Eichele G., Zhang P., Rawls A., Sands A.T., Bradley A., Olson E.N., Harper J.W., Elledge S.J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 267:1995;1024-1027.
15. Yokota Y., Mori S. Role of Id family proteins in growth control. J. Cell. Physiol. 190:2002;21-28.
16. Hamamori Y., Wu H.Y., Sartorelli V., Kedes L. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol. Cell. Biol. 17:1997;6563-6573.
17. Skapek S.X., Rhee J., Kim P.S., Novitch B.G., Lassar A.B. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol. 16:1996;7043-7053.
18. Spicer D.B., Rhee J., Cheung W.L., Lassar A.B. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science. 272:1996;1476-1480.
19. Yang X.L., Matsuura H., Fu Y., Sugiyama T., Miura N. MFH-1 is required for bone morphogenetic protein-2-induced osteoblastic differentiation of C2C12 myoblasts. FEBS Lett. 470:2000;29-34.
20. Lefebvre V. Toward understanding the functions of the two highly related Sox5 and Sox6 genes. J. Bone Miner. Metab. 20:2002;121-130.
21. Mo R., Freer A.M., Zinyk D.L., Crackower M.A., Michaud J., Heng H.H., Chik K.W., Shi X.M., Tsui L.C., Cheng S.H., Joyner A.L., Hui C. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development. 124:1997;113-123.
22. Kim J.G., Armstrong R.C., v Agoston D., Robinsky A., Wiese C., Nagle J., Hudson L.D. Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system. J. Neurosci. Res. 50:1997;272-290.
23. Mao Z., Bonni A., Xia F., Nadal-Vicens M., Greenberg M.E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science. 286:1999;785-790.
24. Geoffroy V., Ducy P., Karsenty G. A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J. Biol. Chem. 270:1995;30973-30979.
25. Nabeshima Y., Hanaoka K., Hayasaka M., Esumi E., Li S., Nonaka I. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:1993;532-535.
26. Hasty P., Bradley A., Morris J.H., Edmondson D.G., Venuti J.M., Olson E.N., Klein W.H. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 364:1993;501-506.
27. Venuti J.M., Morris J.H., Vivian J.L., Olson E.N., Klein W.H. Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 128:1995;563-576.
28. Gao X., Chandra T., Gratton M.O., Quelo I., Prud'homme J., Stifani S., St-Arnaud R. HES6 acts as a transcriptional repressor in myoblasts and can induce the myogenic differentiation program. J. Cell Biol. 154:2001;1161-1171.
29. Dallas P.B., Cheney I.W., Liao D.W., Bowrin V., Byam W., Pacchione S., Kobayashi R., Yaciuk P., Moran E. p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. Mol. Cell. Biol. 18:1998;3596-3603.
30. Nie Z., Xue Y., Yang D., Zhou S., Deroo B.J., Archer T.K., Wang W. A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol. Cell. Biol. 20:2000;8879-8888.
31. Roy K., De La Serna I. L., and Imbalzano A. N. (2002). The myogenic basic helix-loop-helix family of transcription factors shows similar requirements for SWI/SNF chromatin remodeling enzymes during muscle differentiation in culture. J. Biol. Chem.
32. de la Serna I.L., Roy K., Carlson K.A., Imbalzano A.N. MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes. J. Biol. Chem. 276:2001;41486-41491.
33. Kiess M., Gill R.M., Hamel P.A. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene. 10:1995;159-166.
34. Rao S.S., Kohtz D.S. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270:1995;4093-4100.
35. Ohki R., Nemoto J., Murasawa H., Oda E., Inazawa J., Tanaka N., Taniguchi T. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J. Biol. Chem. 275:2000;22627-22630.
36. Zhang Z., Li J., Lantry L.E., Wang Y., Wiseman R.W., Lubet R.A., You M. p53 transgenic mice are highly susceptible to 1,2-dimethylhydrazine-induced uterine sarcomas. Cancer Res. 62:2002;3024-3029.
37. Reshef R., Maroto M., Lassar A.B. Regulation of dorsal somitic cell fates BMPs and Noggin control the timing and pattern of myogenic regulator expression . Genes Dev. 12:1998;290-303.
38. Musgrave D.S., Pruchnic R., Wright V., Bosch P., Ghivizzani S.C., Robbins P.D., Huard J. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone. 28:2001;499-506.
39. Chang C., Holtzman D.A., Chau S., Chickering T., Woolf E.A., Holmgren L.M., Bodorova J., Gearing D.P., Holmes W.E., Brivanlou A.H. Twisted gastrulation can function as a BMP antagonist. Nature. 410:2001;483-487.
40. Hsu D.R., Economides A.N., Wang X., Eimon P.M., Harland R.M. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol. Cell. 1:1998;673-683.
41. Dionne M.S., Skarnes W.C., Harland R.M. Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor beta antagonists. Mol. Cell. Biol. 21:2001;636-643.
42. Reddi A.H. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development noggin, chordin and DAN . Arthritis Res. 3:2001;1-5.
43. Giebel B. The notch signaling pathway is required to specify muscle progenitor cells in Drosophila. Mech. Dev. 86:1999;137-145.
44. Fuerstenberg S., Giniger E. Multiple roles for notch in Drosophila myogenesis. Dev. Biol. 201:1998;66-77.
45. Davis R.L., Turner D.L. Vertebrate hairy and Enhancer of split related proteins Transcriptional repressors regulating cellular differentiation and embryonic patterning . Oncogene. 20:2001;8342-8357.
46. Sasai Y., Kageyama R., Tagawa Y., Shigemoto R., Nakanishi S. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev. 6:1992;2620-2634.
47. Lu J., Webb R., Richardson J.A., Olson E.N. MyoR a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD . Proc. Natl. Acad. Sci. USA. 96:1999;552-557.
48. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling cell fate control and signal integration in development . Science. 284:1999;770-776.
49. Egan S.E., St-Pierre B., Leow C.C. Notch receptors, partners and regulators from conserved domains to powerful functions . Curr. Top. Microbiol. Immunol. 228:1998;273-324.
50. Minoguchi S., Taniguchi Y., Kato H., Okazaki T., Strobl L.J., Zimber-Strobl U., Bornkamm G.W., Honjo T. RBP-L, a transcription factor related to RBP-Jkappa. Mol. Cell. Biol. 17:1997;2679-2687.
51. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1994;1755-1766.
52. Lazaro J.B., Bailey P.J., Lassar A.B. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev. 16:2002;1792-1805.
53. Skapek S.X., Rhee J., Spicer D.B., Lassar A.B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase [see comments]. Science. 267:1995;1022-1024.
54. Rao S.S., Chu C., Kohtz D.S. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:1994;5259-5267.
55. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee J., Hannon G.J., Beach D., Lassar A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1995;1018-1021.
56. Shawber C., Nofziger D., Hsieh J.J., Lindsell C., Bogler O., Hayward D., Weinmaster G. Notch signaling inhibits muscle cell differentiation through a CBF1-independent pathway. Development. 122:1996;3765-3773.
57. Wilson-Rawls J., Molkentin J.D., Black B.L., Olson E.N. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol. Cell. Biol. 19:1999;2853-2862.
58. Nofziger D., Miyamoto A., Lyons K.M., Weinmaster G. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development. 126:1999;1689-1702.
59. Winer J., Jung C.K., Shackel I., Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270:1999;41-49.